Cabaletta Bio, Inc.
NASDAQ:CABABiotechnology
Healthcare
$1.02 +1.23%
+$0.04 today
- Market cap
- $220.03M
- Beta
- 3.23
- P/E (TTM)
- -1.8
- EPS (TTM)
- -$1.57
52W Low $1.26High $4.23
Volume 5.46M
Average 3.33M
Price history
Cabaletta Bio, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-56.41%
Period high
$4.15
Period low
$1.02
Latest
$1.02
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G/A | Nov 12, 2026 | Nov 12, 2026 | |
| 8-K | Nov 9, 2026 | Nov 9, 2026 | |
| SC 13G/A | Nov 6, 2026 | Nov 6, 2026 | |
| SC 13G/A | Nov 6, 2026 | Nov 6, 2026 | |
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| SC 13G/A | Oct 30, 2026 | Oct 30, 2026 | |
| SC 13G/A | Oct 27, 2026 | Oct 27, 2026 | |
| 8-K | Sep 14, 2026 | Sep 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| 8-K | Aug 13, 2026 | Aug 13, 2026 | |
| 10-Q | Aug 13, 2026 | Aug 13, 2026 | |
| SC 13G/A | Aug 12, 2026 | Aug 12, 2026 |
Competitors
Who does Cabaletta Bio, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about CABA's filings, answered from its disclosures.
What is the latest CABA filing?
The latest filing shown is SC 13G/A dated Nov 12, 2026.
How many recent filings does CABA have?
Intrinsic Alpha currently shows 20 recent filings for CABA.
Continue the stock analysis
Jump to another research area for this company.